Subscribe to RSS
DOI: 10.1055/s-2005-916231
© Georg Thieme Verlag KG Stuttgart · New York
Efficient Preparation of Derivatives of Resibufogenin using Microbial Catalytic Technique
Publication History
Received: July 5, 2005
Accepted: September 20, 2005
Publication Date:
30 January 2006 (online)
Abstract
Microbial catalysis is a useful biotechnology in studies on natural products, by which a diversity of novel or active compounds can be obtained. Structural modifications of resibufogenin (1) by hydroxylases, isomerase and glucosyltransferase in Mucor subtilissimus AS 3.2454 were investigated. Eleven products were obtained, and, on the basis of their spectral data, their structures were identified as 12β-hydroxyresibufogenin (2), 11β-hydroxyresibufogenin (3), 16α-hydroxyresibufogenin (4), 12β-hydroxy-3-epi-resibufogenin (5), 12α-hydroxyresibufogenin (6), 1β,11β-dihydroxyresibufogenin (7), 12β,16α-dihydroxyresibufogenin (8), 12α,16α-dihydroxyresibufogenin (9), 7α-hydroxyresibufogenin (10), 1β,12β-dihydroxyresibufogenin (11) and resibufogenin 12-O-β-D-glucoside (12), respectively, of which 3, 5, 7, 11 and 12 are new compounds. This microbial catalytic process was efficient for the production of derivatives of resibufogenin giving 11 products and an overall yield of 93.60 %.
Key words
Resibufogenin - microbial transformation - Mucor subtilissimus - hydroxylation - isomerization - glucosylation
References
- 1 Chen Y, Xiang J, Gu W, Xu M. Chemical constituents of Bufo Siccus . China J Chin Mater Med. 1998; 23 620-1
- 2 Krenn L, Kopp B. Bufadienolides from animal and plant sources. Phytochemistry. 1998; 48 1-29
- 3 Xie J T, Wang H S, Attele A S, Yuan C S. Effect of resibufogenin from toad venom on isolated Purkinje fibers. Am J Chin Med. 2000; 28 187-96
- 4 Xie J T, Dey L, Wu J A, Lowell T K, Yuan C S. Cardiac toxicity of resibufogenin: electrophysiological evidence. Acta Pharmacol Sin. 2001; 22 289-97
- 5 Kamano Y, Kotake A, Hashima H, Inoue M, Morita H, Takeya K. et al . Structure-cytotoxic activity relationship for the toad poison bufadienolides. Bioorg Med Chem. 1998; 6 1103-15
- 6 Terness P, Navolan D, Dufter C, Kopp B, Opelz G. The T-cell suppressive effect of bufadienolides: Structural requirements for their immunoregulatory activity. Int Immunopharmacol. 2001; 1 119-34
- 7 Nogawa T, Kamano Y, Yamashita A, Pettit G R. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese Traditional Drug Ch’an Su. J Nat Prod. 2001; 64 1148-52
- 8 Kamano Y, Pettit G R, Inoue M, Tozawa M, Smith C R, Weisleder D. Synthesis of the 14α- and 16α-epimers of bufotalin acetate and 16-deacetylcinobufagin. J Chem Soc Perkin Trans I 1998: 2037-41
- 9 Gsell L, Christoph T. Reactions with microorganisms. XVI. Toad poison (bufadienolide) conversion by microorganisms. IV. 7β-Hydroxybufalin, 7β-hydroxyresibufogenin, 12α-hydroxyresibufogenin. Helv Chim Acta. 1969; 52 150-65
Dr. Dean Guo
The State Key Laboratory of Natural and Biomimetic Drugs
School of Pharmaceutical Sciences
Peking University
Beijing 100083
People’s Republic of China
Phone: +86-10-8280-1516
Fax: +86-10-8280-2700
Email: gda@bjmu.edu.cn